Delayed clearance of hepatitis B surface antigen and development of hepatitis B surface antibody in a chronic hemodialysis patient
The introduction of hepatitis B vaccination and infection control in 1977 has greatly decreased the prevalence of hepatitis B. Currently, approximately 2.8% of the end-stage renal disease population is hepatitis B positive with a presence in 27.7% of the USA hemodialysis (HD) units according to the...
Main Authors: | Richard Treger, Ramy M Hanna, Brian M Lee, Eduardo A Lopez, James Wilson, Dalila Corry |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2016;volume=27;issue=5;spage=1047;epage=1051;aulast=Treger |
Similar Items
-
Serum anti-hepatitis B surface antigen in hemodialysis patients
by: Rafieian-Kopaei Mahmoud, et al.
Published: (2012-01-01) -
Antibodies to hepatitis B virus surface antigen and <it>interleukin 12</it> and <it>interleukin 18</it> gene polymorphisms in hemodialysis patients
by: Grzegorzewska Alicja E, et al.
Published: (2012-08-01) -
Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
by: Zeynep Gök Sargın
Published: (2023-03-01) -
Hepatitis C virus antibodies in asymptomatic chronic carriers of hepatitis B surface antigen.
by: Henrique Barros, et al.
Published: (1994-12-01) -
PREVALENCE OF HEPATITIS B SURFACE ANTIGEN(HBSAG), ANTIHEPATITIS
B ANTIBODIES(ANTI-HBS), HEPATITIS B CORE
ANTIBODY(ANTI-HBC) AMONG PATIENTS UNDERGOING
HEMODIALYSIS IN HEMODIALYSIS UNIT, RSUP
Dr. SARDJITO, YOGYAKARTA.
by: , JANICE RACHEL THANGA RAJ, et al.
Published: (2014)